Cancer Genomics & Metabolomics

Cancer genomics and metabolomics are two important fields of study that are helping researchers better understand the underlying biology of cancer and identify new targets for cancer treatments.

Cancer genomics includes the study of the genetic changes which occur in cancer cells. These changes can occur in various genes and pathways, leading to abnormal cell growth and division. By analyzing the genetic makeup of cancer cells, researchers can identify mutations and other changes that may be driving tumor growth, and develop new targeted therapies that specifically target these changes.

Both cancer genomics and metabolomics are rapidly advancing fields that are helping to uncover new insights into the biology of cancer and identify new targets for cancer treatments. With ongoing research and advances in these fields, we may continue to see improvements in cancer treatment and outcomes for patients.

    Related Conference of Cancer Genomics & Metabolomics

    July 11-12, 2024

    24th World Congress on Cancer and Diagnostics

    Vancouver, Canada
    July 18-19, 2024

    14th World Congress on Breast Cancer

    Paris, France
    September 16-17, 2024

    9th World Conference on Breast and Cervical Cancer

    London, UK
    September 19-20, 2024

    25th World Congress on Cancer Summit

    Paris, France
    November 25-26, 2024

    7th International Conference on Anti-Cancer Drugs & Therapies

    Vancouver, Canada
    December 10-11, 2024

    8th Global Meeting on Oncology and Radiology

    Dubai, UAE

    Cancer Genomics & Metabolomics Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in